Panbela Therapeutics (NASDAQ: PBLA), a clinical stage company developing disruptive therapeutics for the treatment of patients with urgent unmet medical needs, has released the pricing of its public offering. The public offering is comprised of 20,100,000 shares of its common stock (or prefunded warrants in lieu thereof); the announcement also reported on the pricing of warrants for the purchase of up to 30,150,000 shares of common stock. The offering closed on Oct. 4, 2022. The purchase price was $0.30 per share and associated public warrant. The announcement outlined key information regarding the public warrants: they will have an exercise price of $0.30 per share, are exercisable upon issuance, and will expire five years following the date of issuance. Roth Capital Partners acted as lead placement agent for the offering.
To view the full press release, visit https://nnw.fm/UE74s
About Panbela Therapeutics Inc.
Panbela Therapeutics is a clinical-stage biopharmaceutical company developing disruptive therapeutics for patients with urgent unmet medical needs. Panbela’s lead assets are Ivospemin (SBP- 101) and Flynpovi. For more information about the company, please visit www.Panbela.com.
About NetworkNewsWire
NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) NetworkNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.
To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 888-902-4192 (U.S. Mobile Phones Only)
For more information please visit https://www.networknewswire.com
Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
NetworkNewsWire (NNW)
New York, New York
www.networknewswire.com
212.418.1217 Office
[email protected]
NetworkNewsWire is part of the InvestorBrandNetwork
